Has Joann Salvemini, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,049 in general payments to Joann Salvemini, MD across 5 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Joann Salvemini, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Joann Salvemini, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Joann Salvemini, MD

Dermatology · Stony Brook, NYNPI 1023062973

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $909 of the $1,049 with a category attached, or 86.7%. Every reported general payment came from a single manufacturer, Bristol Myers Squibb. That places this record below the midpoint for dermatology clinicians in NY, where the typical reported total is $2,360.

$1,049in general payments, 2019–2025

Across 5 payments — averaging $209.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bristol Myers Squibb$1K

$191,343in research payments, 2019–2025

Across 25 payments — averaging $7653.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Amgen$171K
Incyte Corporation$21K

What the payments were for

Travel & lodging$90987%
Food & beverage$13913%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bristol Myers Squibb	5	$1,049

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Otezla$891

How this compares

$1,049 in reported general payments places this provider in the 35th percentile of 1,151 dermatology providers in New York.

See all dermatology providers in New York →

Medicare billing

Part B allowed, 2024

$411,390

Medicare patients

1,468

Services billed

4,740

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	24	$86,165
OtezlaApremilast	13	$59,000
Dupixent SyringeDupilumab	13	$44,642
Ketoconazole	205	$3,325
Tacrolimus	24	$3,110
Metronidazole	63	$3,069
Fluorouracil	46	$2,806
Clobetasol Propionate	67	$2,347
Betamethasone Dipropionate	71	$2,029
Triamcinolone Acetonide	137	$1,524
Ammonium Lactate	60	$1,249
Doxycycline Hyclate	35	$916
Clindamycin Phosphate	14	$669
Ciclopirox	19	$556
ValacyclovirValacyclovir Hcl	13	$393

Paid to pharmacies, not to this prescriber.

Other dermatology in Stony Brook

Alexandra GolantNew York$3.6M
David CohenNew York$3M
Michael CameronNew York$2.6M
Saakshi KhattriNew York$2.4M
Amy WechslerNew York$2.4M
Jeffrey WeinbergKew Gardens$2.3M
Joshua ZeichnerNew York$2.1M
Russell CohenOceanside$2.1M
Jeffrey LaducaAuburn$1.9M
Emma GuttmanNew York$1.7M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →